Mirum Pharmaceuticals (stock symbol: MIRM) Logo in transparent PNG and SVG formats

Mirum Pharmaceuticals Logo large

Mirum Pharmaceuticals Logo icon format

Mirum Pharmaceuticals Logo large for dark backgrounds

Mirum Pharmaceuticals Logo icon format for dark backgrounds

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

  • Website domain: mirumpharma.com
  • Employees: 144
  • Marketcap: $0.78 Billion USD

Page last updated on:

February 14th, 2022

Categories: